Kalvista pharmaceuticals, inc. (KALV)
Income statement / Quarterly
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Sep'16Jul'16Jun'16Mar'16Jan'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Revenue

1,577

3,920

3,369

2,927

3,890

5,592

3,718

4,840

2,331

1,127

96

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

-

-

248

197

-

-

-

-

-

-

-

-

-

-

-

-

-

Grant income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

975

-

-

348

-

-

-

-

-

-

-

-

License Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

-

7

7

-

8

7

7

7

8

10

5

6

Operating expenses:
Research and development

11,233

9,789

9,686

11,139

7,650

7,876

8,356

5,852

4,548

4,361

3,476

8,048

3,339

2,929

332

3,395

947

3,532

3,622

4,260

3,533

4,504

3,902

3,031

2,088

1,750

1,425

General and administrative

3,068

3,420

3,247

3,046

2,900

2,609

2,371

1,957

2,129

2,703

2,073

1,467

5,026

1,293

2,080

2,700

2,604

1,543

541

1,317

1,373

1,170

1,006

794

1,490

691

437

Restructuring and lease termination charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,420

-

-

-

-

-

-

-

-

-

-

Impairment of long-lived assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

1,460

-

-

-

-

-

-

-

-

-

Total operating expenses

14,301

13,209

12,933

14,185

10,550

10,485

10,727

7,809

6,677

7,064

5,549

6,095

8,365

4,222

2,412

6,095

6,971

6,535

4,163

5,577

4,906

5,674

4,908

3,825

3,578

2,441

1,862

Operating loss

-12,724

-9,289

-9,564

-11,258

-6,660

-4,893

-7,009

-2,969

-4,346

-5,937

-5,453

-4,853

-8,117

-4,025

-2,405

-5,120

-6,964

-6,528

-3,815

-5,569

-4,899

-5,667

-4,901

-3,817

-3,568

-2,436

-1,856

Other income:
Interest income

372

505

590

381

723

204

89

65

14

1

2

-10

7

10

19

14

20

12

20

0

2

2

-

-

1

-

-

Foreign currency exchange gain

138

560

-453

-35

248

-231

67

262

-1,887

83

-32

-180

-195

352

-

1,394

-

-

1,297

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

-

406

88

-

88

95

169

836

562

357

83

80

Loss on extinguishment of convertible promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,177

-

-

-

-

-

Other income

2,923

2,321

2,089

2,510

1,733

1,616

1,823

1,985

985

867

555

1,667

661

368

1

275

0

-3

546

-3

1

-1

553

-

-71

-117

-

Other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-79

Total other income

3,433

3,386

2,226

2,856

2,704

1,589

1,979

2,312

-888

951

525

850

473

730

-

1,683

-

-

1,863

-

-

-

-

-

-

-199

-159

Net loss

-9,291

-5,903

-7,338

-8,526

-3,956

-3,304

-5,030

-657

-5,234

-4,986

-4,928

-1,224

-7,644

-3,295

-2,385

-3,437

-7,350

-6,607

-1,952

-5,659

-4,991

-9,012

-5,184

-4,714

-3,995

-2,635

-2,015

Other comprehensive income (loss):
Foreign currency translation adjustments

142

495

-89

-33

-97

193

-1,320

-973

2,434

-43

116

-8,381

166

1,325

-

4,322

-

-

-3,622

-

-

-

-

-

-

-

-

Unrealized holding gains on available-for-sale securities

40

28

28

-

232

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification adjustment for realized (gain) on available-for-sale securities included in net loss

100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other comprehensive income (loss)

82

523

-61

-

135

193

-1,320

-

2,434

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-9,209

-5,380

-7,399

-8,351

-3,821

-3,111

-6,350

-1,630

-2,800

-5,029

-4,812

-12,608

-7,478

-1,970

-

885

-

-

-5,574

-

-

-

-

-

-

-

-

Net loss attributable to common stockholder

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,015

Net loss per share to common stockholders, basic and diluted

-0.52

-0.33

-0.42

-0.46

-0.23

-0.22

-0.47

-0.03

-0.49

-0.50

-0.51

-3.07

-1.03

-5.98

-0.09

-6.66

-0.28

-0.25

-4.85

6.67

-0.19

-0.40

-7.38

-7.27

-5.89

-4.26

-4.39

Weighted average common shares outstanding, basic and diluted

17,838

17,823

17,488

17,183

17,231

15,108

10,799

10,781

10,788

10,003

9,713

-41,748

7,657

709

26,343

671

26,334

26,332

630

26,683

26,322

22,622

701

694

678

618

459